<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Cancer</journal-id><journal-title-group><journal-title>British Journal of Cancer</journal-title></journal-title-group><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10098764</article-id><article-id pub-id-type="pmc">2362235</article-id><article-id pub-id-type="pii">6690197</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690197</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Grunfeld</surname><given-names>E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Gray</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Mant</surname><given-names>D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Yudkin</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Adewuyi-Dalton</surname><given-names>R</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Coyle</surname><given-names>D</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Cole</surname><given-names>D</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Stewart</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Fitzpatrick</surname><given-names>R</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vessey</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">Division of Public Health and Primary Health Care, Institute of Health Sciences, University of Oxford, Oxford, OX3 7LF, UK</aff><aff id="aff2">Ottawa Regional Cancer Centre, Department of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8L6, Canada</aff><aff id="aff3">Northamptonshire Centre for Oncology, Northampton General Hospital, Northampton, NN1 5BD, UK</aff><aff id="aff4">Health Economics Research Centre, Institute of Health Sciences, University of Oxford, Oxford, OX3 7LF, UK</aff><aff id="aff5">Department of Primary Medical Care, University of Southampton, Southampton, SO1 6ST, UK</aff><aff id="aff6">Clinical Epidemiology Unit, Loeb Research Institute, University of Ottawa, Ontario, Ottawa, K1Y 4E9, Canada</aff><aff id="aff7">Princess Margaret Hospital, Swindon, SN1 4JU, UK</aff></contrib-group><author-notes><corresp id="caf1"><label>*</label>Ottawa Regional Cancer Centre, Department of Medicine, University of Ottawa, 501 Symth Road, Ottawa, Ontario K1H 8L6, Canada</corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>1999</year></pub-date><volume>79</volume><issue>7-8</issue><fpage>1227</fpage><lpage>1233</lpage><history><date date-type="received"><day>18</day><month>05</month><year>1998</year></date><date date-type="accepted"><day>30</day><month>07</month><year>1998</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 1999 Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><abstract><p>A randomized controlled trial (RCT) comparing primary-care-centred follow-up of breast cancer patients with the current standard practice of specialist-centred follow-up showed no increase in delay in diagnosing recurrence, and no increase in anxiety or deterioration in health-related quality of life. An economic evaluation of the two schemes of follow-up was conducted concurrent with the RCT. Because the RCT found no difference in the primary clinical outcomes, a cost minimization analysis was conducted. Process measures of the quality of care such as frequency and length of visits were superior in primary care. Costs to patients and to the health service were lower in primary care. There was no difference in total costs of diagnostic tests, with particular tests being performed more frequently in primary care than in specialist care. Data are provided on the average frequency and length of visits, and frequency of diagnostic testing for breast cancer patients during the follow-up period. &#x000a9; 1999 Cancer Research Campaign</p></abstract><kwd-group><kwd>breast cancer</kwd><kwd>economic evaluation</kwd><kwd>follow-up care</kwd><kwd>randomized controlled trial</kwd><kwd>primary care</kwd></kwd-group></article-meta></front></article>